NuVasive to Acquire SafePassage

NuVasive, Inc., headquartered in San Diego, California, is all set to acquire New York-based SafePassage, manufacturer of intraoperative neurophysiological monitoring (IONM) services.

According to NuVasive, SafePassage complements their current NCS (NuVasive Clinical Services) business in part because it has a limited geographic overlap with NuVasive’s existing healthcare accounts. Buying SafePassage also helps NuVasive grow its services business and pulls NuVasive deeper into key strategic markets in the New York metropolitan area and more generally along the East Coast.

“The acquisition of SafePassage expands our ability to transform how spine procedures are approached, measured and valued from a clinical and economic perspective,” said Skip Kiil, NuVasive executive vice president, Global Commercial. “As the only spine company in the world with dedicated neuromonitoring services operating at this elevated scale, and now with increased case coverage, we are uniquely positioned to deliver greater value across our procedurally-integrated portfolio.”

“Just as important, the highly trained and well-respected SafePassage leadership and clinicians have earned the industry reputation of being among the best in the business, and we’re excited to partner with them to provide consistent and quality care to hundreds of surgeons and thousands of patients each year,” continued Kiil.

“For more than a decade, the team at SafePassage has been dedicated to serving patients and surgeons with premium quality intraoperative neurophysiological monitoring services to improve patient outcomes and reduce economic risk for hospitals and surgeons,” said Dan Siegel, SafePassage CEO. “We are extremely passionate about our vision to eradicate preventable healthcare injury, the third leading cause of death in the United States, and I look forward to joining forces with NuVasive to further our mission worldwide.”

Skip Kiil told OTW, “It’s really a combination of right place, right time, right company. Not only is SafePassage complementary to NuVasive business operations from a geographical standpoint—with a strong presence in New York, Massachusetts, Connecticut, Georgia and Florida—it also brings with it strong clinical expertise, leadership and aligns seamlessly with our overall strategy to grow the service side of our business. Adding SafePassage to the NuVasive family solidifies us as the largest provider of intraoperative neurophysiological monitoring services to U.S. healthcare systems and providers.”

“We saw an opportunity to add to the momentum we created when we started NuVasive Clinical Services about 18 months ago. SafePassage adds to our clinical services expertise and at the same time allows us to further differentiate ourselves as a comprehensive solutions leader in a highly competitive spine market. The acquisition immediately expands the NCS surgeon/hospital partner reach with a total of 550 neurophysiologists and oversight physicians to help more hospitals, surgeons and patients.”